Organization · Venture Capital
Aspire Ventures, LLC
Aspire Ventures, LLC is a venture capital firm based in Lancaster, Pennsylvania, focused on transforming healthcare through precision medicine and technologies leveraging AI and IoT. The firm supports early-stage ventures with a unique ecosystem approach.
Overview
What Aspire Ventures, LLC does
What Aspire Ventures, LLC is
Aspire Ventures, LLC is a venture capital firm based in Lancaster, Pennsylvania, focused on transforming healthcare through precision medicine and technologies leveraging AI and IoT. The firm supports early-stage ventures with a unique ecosystem approach.
How it participates in the startup ecosystem
The current public profile supports funder and publisher capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder · Publisher
- Last reviewed
- March 31, 2026
Official channels
Find Aspire Ventures, LLC elsewhere
Open the official website or a supported primary organization account.
Capability profile
Aspire Ventures, LLC as a funder
Investment thesis
Precision medicine technologies that leverage AI and IoT to deliver affordable, individualized healthcare solutions at scale.
Focus narrative
Aspire Ventures invests in early-stage ventures within the healthcare sector, particularly those utilizing AI and IoT to enhance precision medicine. The organization emphasizes a unique structure that supports ventures through a comprehensive ecosystem of strategic partnerships and accelerators, facilitating each step of the venture development process from ideation to market adoption.
Value beyond capital
Aspire Ventures provides a unique ecosystem model that spans ideation through reimbursement, offering health system data and clinical expertise directly to portfolio companies. Their proprietary A2I Platform reduces data science resources needed to build AI-powered health solutions, and they facilitate market adoption through programs like the Smart Health Innovation Lab.
Terms and economics
- Typical check
- $3,000,000–$30,000,000
- Sweet spot
- $10,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Series D · Series E · Series F · Growth Equity
- Sectors
- Healthcare · AI · IoT · Biotech · Fintech · Medical Devices · Diagnostics
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 6
Portfolio context
Notable portfolio companies include: Appmobi: Provides cognitive cybersecurity tools for mobile applications and IoT devices. Clio Health: A mobile health plan that personalizes health and wellness experiences for its members. Connexion Health: Integrates biometric scans and AI-assisted applications for a connected healthcare experience. MedStatix: A patient experience platform that analyzes patient feedback to improve healthcare delivery. NeuroFlow: A mental health technology platform that enhances patient engagement and wellness. OneOme: A pharmacogenomics company that aids in informed prescription decisions through its RightMed® test.
Capability profile
Aspire Ventures, LLC as a publisher
Editorial focus
Aspire Ventures, LLC is dedicated to advancing precision medicine technologies, focusing on early-stage ventures that leverage artificial intelligence (AI) and the Internet of Things (IoT) to deliver affordable, individualized healthcare solutions. The organization operates the Aspire Ventures Precision Medicine Fund (AVP), which aims to fast-track the development of innovative healthcare products while emphasizing capital efficiency and reducing the time and resources required for market adoption.
Audience value
Aspire Ventures provides a unique ecosystem model that supports portfolio companies from ideation through market adoption and reimbursement, offering direct access to health system data and clinical expertise.
Format and cadence
- Content formats
- podcast and blog
- Primary platform
- Website
Availability
- Guest pitch state
- Not currently accepting
Audience and focus
- Audience
- Investors · Founders
- Sectors
- Healthcare · Precision Medicine · Medical Devices · Diagnostics
- Regions
- United States
Flagship work and coverage
Flagship properties
The Aspire Ventures Precision Medicine Fund (AVP) is the main fund managed by Aspire Ventures, with a target size of $300M and an initial seed of $30M. The organization also runs the Smart Health Innovation Lab, a 12-week healthcare technology certification program.
Notable coverage
Aspire Ventures has been featured in various publications, including GlobeNewswire and MedCity News, highlighting the launch of their fund and their unique approach to venture capital in the healthcare sector.
Common questions
What to know about Aspire Ventures, LLC
Upseed classifies Aspire Ventures, LLC under the Venture Capital organization type. Its current public profile includes funder and publisher capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 31, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.